Endeavor

New Combination Therapy Brings Hope to Bladder Cancer Patients

Innovative treatment shows high success rates in overcoming standard therapy resistance

Using First-of-its-Kind Vaccine to Treat Leptomeningeal Disease

Dendritic cell vaccine may prolong survival well past dismal prognosis

Evaluating the Microbiome in Patients with Triple Negative Breast Cancer

Moffitt-led Pilot study looked at gut microbiome as biomarker for treatment response

‘Daily Diary’ Study Monitors Caregiver Stress and Mood

It’s part of a larger study to support caregivers and improve patient outcomes

Are Cancer Survivors Making Health a Priority?

Study shows only 4% of cancer survivors adhere to ACS health and exercise guidelines

Moffitt Hosts Migrant and Farmworker Health and Wellness Expo

Free wellness event for rural community screened more than 100 participants

How Should Patients with Cancer Prepare for a Hurricane?

Talk to your health care team about how to receive care if a storm hits

Moffitt is First in U.S. to Offer New Lung Cancer Therapy

FDA recently approved tarlatamab for extensive stage small cell lung cancer

Moffitt Fellow Receives Urology Care Foundation Research Scholar Award

Joshua Linscott, MD, PhD studies the potential of urinary tumor DNA and circulating tumor DNA in bladder cancer